Sjogren's Syndrome Drug Pipeline Report 2023: Comprehensive Insights about 20+ Companies and 25+ Pipeline Drugs
28 nov. 2023 07h38 HE
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Sjogren's syndrome - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Sjogren's syndrome - Pipeline...
XELJANZ for Ulcerative Colitis (UC) Pipeline Report 2023: Drug Market Insights and Forecasts, 2019-2032 - Focus on 7 Major Markets
23 nov. 2023 11h23 HE
|
Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "XELJANZ Market Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. "XELJANZ Market Drug...
Liposomal Cyclosporine A Emerging Drug Insights and Market Forecasts, 2017-2023 & 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
22 nov. 2023 09h08 HE
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report...
Immunology Collaboration and Licensing Agreements Analysis Report 2023
17 nov. 2023 06h13 HE
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Immunology Collaboration and...
Xerostomia (Dry Mouth Disease) Therapeutics Market - Global Industry Trends, Share, Size, Growth, Opportunities and Forecasts, 2022-2023 & 2028
08 nov. 2023 05h18 HE
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been...
Global Autoimmune Collaboration and Licensing Deals Analysis Report and Directory 2023
07 nov. 2023 04h53 HE
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The "Autoimmune Collaboration...
Cloud Gaming's Meteoric Rise: How 5G and Cutting-Edge Tech are Transforming the Gaming Landscape
02 nov. 2023 08h18 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Opportunity Assessment of Cloud Gaming Evolution in the 5G and 6G Era" report has been added to ResearchAndMarkets.com's offering. The cloud gaming...
Global CD3 Antibodies Market 2023-2028: New-Generation CD3 Antibodies Targeting Diverse Indications Gain Ground
02 nov. 2023 07h43 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
JAK Inhibitors Market Surges as Autoimmune Diseases Demand Cutting-Edge Solutions, 2032F: Revenues for Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, and Other Inhibitor Types
01 nov. 2023 08h18 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Janus Kinase (JAK) Inhibitors Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global Janus Kinase (JAK)...
Acute Myeloid Leukemia (AML) Therapeutics Market Set to Reach $3.7 Billion by 2032: New Pipeline Agents Drive Growth
31 oct. 2023 08h58 HE
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...